HOME >> BIOLOGY >> NEWS
Wanted: Companies to license life-saving breath test developed at NJIT

Menssana Research, located in the small business incubator program at New Jersey Institute of Technology (NJIT), is seeking companies to license its federally-approved Heartsbreath test, a life-saving technology. Since 1985, Menssana has been developing a unique series of two-minute breath tests. The Heartsbreath Test is the company's first to secure Food and Drug Administration (FDA) approval. Several more tests, including one for lung cancer, are in the pipeline.

The Heartsbreath test determines whether patients with heart transplants are showing signs of rejecting their new heart. It is non-invasive and risk-free. FDA approved the test for clinical use as an adjunct to biopsy.

"We are at the point where it makes sense to interest other companies in licensing this breath test so that it can be sold to hospitals and doctors," said Menssana founder and CEO Michael Phillips, MD. Phillips is a clinical professor of internal medicine at New York Medical College, Valhalla, NY, and a Fort Lee resident. The Enterprise Development Center (EDC) at NJIT, which keeps new technology businesses alive and growing in New Jersey, operates the incubator program.

"One day I hope to see our breath testing equipment, which is relatively small and easy to use, in every physician's office and hospital lab," Phillips added. "Our tests can not only save lives, but they can make medicine less frightening for millions of people," (EDITOR'S NOTE: To interview Phillips either in his lab or by telephone, contact Sheryl Weinstein at 973-596-3436.)

"Doctors have used breath to uncover disease since the time of Hippocrates in Ancient Greece. We've known for more than 2000 years that a diabetic's breath smells fruity, like rotten apples. We now know that it's because of the acetone in their breath. Patients with failing kidneys have breath that smells like urine, and diseases of the liver and the lungs also have distinctive odors. We've taken ancient
'"/>

Contact: Sheryl Weinstein
sheryl.m.weinstein@njit.edu
973-596-3436
New Jersey Institute of Technology
10-Aug-2005


Page: 1 2 3

Related biology news :

1. Companies license real-time pathogen detection technology developed at Kent State, NEOUCOM
2. University of Colorado licenses two influenza virus detection discoveries to Quidel Corp.
3. Macrochem acquires option to license pexiganan
4. Brandeis and Brigham and Womens Hospital license technology for Gauchers to Amicus Therapeutics
5. University of Colorado influenza chip licensed by Quidel Corp. of San Diego
6. Rensselaer licenses microscope technology to Thorlabs
7. Columbia University licenses next-generation DNA sequencing technology
8. Case Western Reserve University licenses methoxyamine to Tracon
9. Yale licenses potential anti-HIV agent to Oncolys BioPharma of Japan
10. Mount Sinai School of Medicine licenses avian flu vaccine to Avimex
11. Yale ovarian cancer detection technology licensed in China by SurExam

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/5/2020)... ... June 04, 2020 , ... Murrieta Genomics has announced that its ... simplified sample preparation for Next Generation Genomic Sequencing (NGS) . This is the ... complexity of sample preparation. , “I have been at the bench for over 20 ...
(Date:6/5/2020)... ... 04, 2020 , ... Greffex, a pioneering vaccine and gene therapy company based ... understands the need for a global perspective to make an impact in a post ... will serve as an independent, director of the company. , “The Greffex board is ...
(Date:5/30/2020)... Calif. (PRWEB) , ... May 29, 2020 , ... ... enabler of digital transformation for enterprises globally, has collaborated with EchoNous Inc. to ... FDA. It can measure systolic heart function, which has been clinically tested ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... (PRWEB) , ... July 30, ... ... of cloud-based software for the life sciences industry, today announced the release ... platform designed specifically for Medical Science Liaisons (MSLs) and other field medical ...
(Date:7/18/2020)... ... July 17, 2020 , ... dicentra ... life sciences and food industries, is pleased to announce that Charles Galea has ... Business Development. , Charles is an accomplished and results-driven sales executive with over ...
(Date:7/7/2020)... ... July 06, 2020 , ... R3 International is now ... up to 200 million stem cells. Depending on the patient's condition, treatment may be ... US will die having some form of Alzheimers dementia, and the incidence continues to ...
(Date:6/28/2020)... ... June 25, 2020 , ... The Indoor Lab, a ... Safe Space™ for businesses of all types to ensure cleanliness, distancing and occupancy with ... , A Safe Space™ enabled business will provide a health performance index system that ...
Breaking Biology Technology:
Cached News: